STELLA
News

Our activities

September 03 2019

COMPANY NAME CHANGE

Latest
News

09 May 2024

EUROPEAN COMMISSION LAUNCHES THE CRITICAL MEDICINES ALLIANCE TO HELP PREVENT AND ADDRESS SHORTAGES OF CRITICAL MEDICINE

The European Commission’s Health Emergency Preparedness and Response Authority (HERA), working with the Belgian Presidency of the Council of the EU, have today launched the Critical Medicines Alliance at the margins of the informal EPSCO Council meeting of health ministers, as part of the actions to build a strong European Health Union. The Alliance brings

28 Mar 2024

HO CHI MINH CITY TO HAVE COUNTRY’S FIRST LARGEST PHARMACEUTICAL INDUSTRIAL PARK

Under the People’s Committee of Ho Chi Minh City-approved project, the southern metropolis will have the country’s first largest medical and pharmaceutical industrial park. The city Department of Health today said that the municipal People’s Committee has just issued the Decision No. 657/QD-UBND to approve the Project ‘Developing Ho Chi Minh City’s pharmaceutical industry to

13 Mar 2024

STELLAPHARM WAS LISTED TOP 10 FASTEST GROWING ENTERPRISES IN VIETNAM IN 2024

The top 10 businesses consist of Binh Thuan Plastic Group JSC, HD Securities Corporation, Orient Securities Corporation, Imedia Technology and Services JSC, SOL E&C Construction Investment JSC, Vietnam Vitadairy Milk JSC, Taseco Land Investment JSC, Stellapharm J.V. Co. Ltd., CNC Technology Solutions JSC, and Bee Logistics Corporation. The top 10 in the 2024 list of

07 Mar 2024

AMENDED PHARMACY LAW MUST SUPPORT FOREIGN ENTERPRISES IN VIETNAM

The amended Law on Pharmacy is key in ensuring comprehensive and adequate healthcare resources for the people. HÀ NỘI — Deputy Prime Minister Trần Hồng Hà emphasised that the amended Law on Pharmacy must include regulations to support foreign pharmaceutical enterprises to invest in drug production and technology transfer in Vietnam. Speaking at a meeting

28 Feb 2024

PHARMACEUTICAL INDUSTRY MUST BE MANAGED UNDER MARKET RULES: DEPUTY PRIME MINISTER

Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and cheapest prices during a meeting in Hanoi. Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and

22 Feb 2024

POPULAR DRUGS MUST BE BID CENTRALLY

Drugs that are commonly used and have large volumes must be subject to centralized national or local bidding and selection of qualified manufacturers, Deputy Prime Minister Tran Hong Ha requested. Chairing a meeting on the draft decree guiding the 2023 Bidding Law on contractor selection, Deputy Prime Minister Tran Hong Ha said that in addition

19 Feb 2024

WHY IS IT DIFFICULT FOR PATIENTS TO ACCESS NEW DRUGS?

Only 42 new drugs out of 460 types circulated globally are available in Vietnam, due to long licensing procedures and time, affecting patients. On January 21, a representative of the Ministry of Health said that generic drug prices in Vietnam are low compared to countries in the ASEAN region (for most main treatment groups). While

08 Feb 2024

HIGH GROWTH POTENTIAL IN PHARMACEUTICAL INDUSTRY

It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains dominated by imported drugs and extend their international reach. Vietnam’s pharmaceutical market has significant potential. The Health Ministry

06 Feb 2024

PROPOSING NEW REGULATIONS ON CLINICAL DRUG TRIALS

The Ministry of Health is drafting a Circular amending and supplementing a number of articles of Circular 29/2018/TT-BYT dated October 29, 10 of the Minister of Health regulating clinical drug trials. According to the provisions of Circular 29, regarding the legality of clinical drug trial records: The registration application and the content of the registration

03 Feb 2024

INNOVATIVE MEDICINE SALES TOP THE LIST FOR MULTINATIONALS

Multinational corporations are giving priority to bringing more innovative medicines to Vietnam to tap into growing local demand. Pfizer plans to bring numerous innovative medicines to Vietnam over the next four years. This is in line with its global strategy, as the company has made significant progress towards launching 19 new products over an 18-month

31 Jan 2024

THE GAME-CHANGERS IN PHARMACEUTICALS

Innovative pharmaceuticals are emerging as a game-changer reshaping the industry, which is urging Vietnamese authorities to have supporting policies to tap into new potential. At Pfizer, new innovative vaccines are being studied to keep abreast of new viruses and bacteria that threaten human lives and livelihoods. They include a two-in-one flu and coronavirus jab, and

26 Jan 2024

VIETNAM’S PHARMACEUTICAL INDUSTRY SETS DEVELOPMENT TARGETS FOR THE NEXT DECADE

By 2030, Vietnam will become a center for manufacturing or processing of, and transfer of technologies for, brand-name medicines in the ASEAN region. Under Prime Minister Decision 1165/QD-TTg, approving the National Strategy for development of the domestic pharmaceutical industry through 2030, with a vision toward 2045, it is expected that the domestic pharmaceutical industry’s production

17 Jan 2024

INCENTIVES PROPOSED FOR DEVELOPMENT OF PHARMACEUTICAL INDUSTRY

The Ministry of Health has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry. The Ministry of Health (MOH) has released a draft Law Amending the 2016 Law on Pharmacy, providing many attractive incentives for boosting the development of the pharmaceutical industry.The

12 Jan 2024

MEDICINE PRICES IN VIETNAM IN LOWER RANGE IN ASIA-PACIFIC: CONFERENCE

Medicine prices in Vietnam are in the lower range compared to those in other countries in the region, heard the Asian Federation for Pharmaceutical Sciences (AFPS) Conference 2023 that is taking place in Hanoi from November 8-10, 2023. Vice Health Minister Nguyen Thi Lien Huong speaks at the event (Photo: VNA) Themed “Collaboration for Breakthroughs

10 Jan 2024

IT IS TIME FOR FOREIGN-INVESTED PHARMACEUTICAL COMPANIES TO EXPANDED

With a large population and a growing demand for pharmaceuticals, Vietnam currently ranks among the top 17 countries with the highest pharmaceutical industry growth rates globally. According to the Pharmaceutical Industry Development Program, by 2025, domestically produced drugs are expected to account for 75% of consumption and 60% of market value. Additionally, it is projected

08 Jan 2024

FORUM DISCUSSES NEW APPROACHES FOR PHARMA-HEALTHCARE DEVELOPMENT IN VIETNAM

New approaches for pharma-healthcare development in Vietnam were the main topic of discussion at a forum in Hanoi on July 20, 2023. At the event, held by the Dau tu (Investment Review) Newspaper, participants heard that the investment trend in the medicine and pharmacy fields changed a lot in the direction of focusing on innovation,

06 Jan 2024

POLICY BREAKTHROUGH NEEDED TO BETTER ATTRACT INVESTMENT TO PHARMA SECTOR: EXPERT

The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam less attractive to foreign investors. The lack of a breakthrough in vision and infeasible legal policies, worsened by complicated administrative procedures in pharmacy sector, are among limitations that make Vietnam

04 Jan 2024

VIETNAM MUST CLEARLY DETERMINE PHARMACEUTICAL SECTOR’S GOALS FOR THE FUTURE

The pharmaceutical sector plays an important role in healthcare, meaning development goals must be established. Deputy Prime Minister Trần Hồng Hà made the statement on Wednesday afternoon after hearing a report on the draft National Strategy for the development of Việt Nam’s pharmaceutical sector by 2030. Hà said the draft strategy not only sets out

28 Dec 2023

EU PUBLISHES PROPOSED DRUG LAWS OVERHAUL, SETTING UP TUSSLE WITH INDUSTRY

LONDON, April 26, 2023 (Reuters) – Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere. The biggest overhaul of existing medical laws in two decades is aimed at ensuring all Europeans

26 Dec 2023

INNOVATE TO ELEVATE VIETNAM’S HEALTHCARE INDUSTRY

The “Healthcare Innovation Forum”, a platform that brings together local and international experts to discuss and share experiences on innovative solutions in building a sustainable healthcare system worldwide and to drive the adoption of innovative approaches and technologies to transform healthcare in Vietnam. Diseases never stop developing, nor does innovation to deal with these obstacles.

22 Dec 2023

VIETNAM REALISES PHARMACEUTICAL INDUSTRY DEVELOPMENT STRATEGY

Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health Organisation, according to the National Strategy for Pharmaceutical Industry Development by 2023, with a vision toward 2045. Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health

20 Dec 2023

HO CHI MINH CITY PLANS TO BUILD 300 – HECTARE PHARMACEUTICAL INDUSTRIAL PARK

The Ho Chi Minh City Department of Health is seeking feedback on the plan to construct a 300-hectare pharmaceutical industrial park during the 2025-30 period, a step to prepare for the city’s export of medical products in the future. People work inside a medical laboratory in Ho Chi Minh City – Photo: DUYEN PHAN / Tuoi

19 Dec 2023

SHORTEN LICENSING PROCEDURES, ENCOURAGE INVESTMENT, AND TRANSFER PHARMACEUTICAL TECHNOLOGY

The Circular is an important legal basis for attracting investment activities and transferring technology for drug production, especially original brand name drugs, patented drugs, specialized drugs, special treatments, and prescription drugs. generic drugs in the form of high-tech dosage forms, vaccines, reference biological products, and similar biological products according to the orientations in the “Program

18 Dec 2023

BIG PHARMA BETS ON AI TO SPEED UP CLINICAL TRIALS

Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial

14 Dec 2023

VIETNAM AIMING TO BECOME REGIONAL PHARMACEUTICAL PRODUCTION CENTER

Vietnam has set a target of becoming a high-value pharmaceutical production center in the region under its strategy for the development of the pharmaceutical sector by 2030 with a vision to 2045. Under the strategy, which was approved by Deputy Prime Minister Tran Hong Ha on October 9, Vietnam will strive to develop its pharmaceutical

13 Dec 2023

VIỆT NAM’S PHARMACEUTICAL INDUSTRY DEVELOPMENT STRATEGY

Việt Nam has set its sights on becoming a high-value pharmaceutical production hub within the region.Deputy Prime Minister Trần Hồng Hà recently backed a decision that has been hailed a significant milestone in Việt Nam’s pharmaceutical sector. Signed on October 9, Decision No. 1165/QĐ-TTg has approved the National Strategy for developing Việt Nam’s pharmaceutical industry

11 Dec 2023

315 DRUGS ARE PROPOSED TO APPLY PRICE NEGOTIATION

The Ministry of Health is drafting a Circular promulgating a list of drugs, testing supplies, and medical equipment eligible for price negotiation and stipulating the process and procedures for selecting contractors for applicable bidding packages. form of price negotiation. According to the draft, the construction of the drug list is applied in the form of

09 Dec 2023

PHARMACEUTICAL INDUSTRY STRIVES TO PRODUCE NEW DRUG FORMS

Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming

07 Dec 2023

PHARMACEUTICAL COMPANIES URGED TO INVEST IN R&D, IMPROVE COMPETITIVENESS

It is critical for pharmaceutical companies to improve competitiveness with a focus on research and development (R&D), production technology and digitalisation. According to experts, this will help them expand their shares in the domestic market which remains being dominated by imported drugs and extend their international reach.Vietnam’s pharmaceutical market has significant potential. The Ministry of

05 Dec 2023

OVERVIEW OF VIETNAM’S PHARMACEUTICAL MANUFACTURING INDUSTRY 2023. WHAT DIRECTION FOR PHARMACEUTICAL ENTERPRISES?

Despite having a good market, the pharmaceutical manufacturing in Vietnam still faces many difficulties. This difficulty comes from industry competition, world competition and technological development. In order for the pharmaceutical manufacturing to develop, what should pharmaceutical enterprises do? Overview of Vietnam’s pharmaceutical manufacturing industry 2023.The market for the pharmaceutical industry in Vietnam is relatively active:The

04 Dec 2023

TOP 10 REPUTABLE PHARMACEUTICAL COMPANIES IN 2023

On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;

03 Dec 2023

A FOCUS ON THE IMPROVEMENT OF PEOPLE’S LIVES BY PROVIDING EFFECTIVE AND AFFORDABLE TREATMENTS.

By Mr. Ong Van Dung, General Director, Stellapharm Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with European

26 Jun 2023

THROUGH THE MPP ORGANIZATION, STELLAPHARM GETS THE 3rd APPROVAL TO PRODUCE SHIONOGI’S COVID-19 ORAL PILL

As one of seven generic drug manufacturers selected by MPP and becoming a sub-licensee of Shionogi – a Japanese pharmaceutical manufacturer to produce of XOCOVA™ drug, generic version. Stellapharm is honored and proud to have contributed to repelling the COVID-19 pandemic with drugs. This is the third oral product in the world to be recognized

01 Oct 2021

Merck says research shows its COVID-19 pill works against variants

Sept 29 (Reuters) – Laboratory studies show that Merck & Co’s (MRK.N) experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does not target the spike protein of the virus – the target of

27 Apr 2020

STELLAPHARM SUPPORTS EUROPEAN PARTNERS IN COVID-19 PANDEMIC

Since the beginning of February this year, many consignments of Stella’s pharmaceutical products with a total of nearly 200 million units have been urgently exported by air to markets in Germany, France, Austria, Belgium, Ireland, etc.

17 Mar 2020

GROUNDBREAKING CEREMONY FOR HORMONE – STEROID – OINTMENT FACTORY COMPLYING WITH EU-GMP AND PIC/S

This will be the first steroid-hormone pharmaceutical factory in Vietnam and among a few ASEAN factories built in compliance with European Standards for this line of products.

03 Sep 2019

COMPANY NAME CHANGE

Due to our strategic development of the Company, we are pleased to announce the change of Company Name: STADA – VN JOINT VENTURE CO., LTD. officially changed its name to STELLAPHARM J.V. CO., LTD. since 16 August 2019.
Address, Tax code, Telephone/Fax Number remains unchanged.

13 May 2019

EU-GMP INSPECTION, 2019

“Accrediting the fifth EU-GMP is one of our commitment on maintaining highest EU standards and quality of products with affordable prices” said by Choo Yan Ho, the Chairman.

18 Feb 2019

LAUNCHING HEPATITIS C PRODUCT “LESOVIR” IN VIETNAM

Lesovir is manufactured by its EU-GMP facility and distributed via exclusive distributor, Khuong Duy Pharma Co., Ltd. The product is a fixed-combination preparation of Ledipasvir 90 mg and Sofosbuvir 400 mg) is an oral drug used for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection which are common types in Asia including Vietnam.

14 Jun 2016

EU-GMP INSPECTION, 2016

On 15 March 2016, the fourth EU-GMP Inspection was conducted at STADA – VN J.V. Co., Ltd., Binh Duong Branch, currently known as STELLAPHARM J.V. Co., Ltd. – Branch 1

25 May 2015

JAPAN GMP ACCREDITATION, 2015

On 06 January 2015, STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), was appreciated by Ministry of Health, Labour and Welfare (the “MHLW”) issued the certificate of Japan GMP for the product of Soleton 80 with its composition and strength: Zaltoprofen 80 mg

09 Aug 2013

EU-GMP INSPECTION, 2013

On 19 March 2013, the third EU-GMP Inspection was conducted in five continuous days at STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “Company” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued

17 Oct 2011

Conferences on Orlistat STADA at Bien Hoa City

In the meeting, besides the feedback on how to choose a safe diet pill without any active elements which may cause harmful effect to health, Consultants of STADA-VN JOINT VENTURE CO., LTD also held discussion to explain the efficiency of the productsas well as consulted various diet assistance methods which can bring the best effect.

20 Aug 2011

WHO INT’L INSPECTION

From August 15 – 19, 2011, the delegates from WHO International have inspected STADA plant at VSIP.

20 Jun 2011

Customer Conference on 18 June 2011, in Binh Duong

STADA-VN has been acknowledged as one of the most prestigious enterprises on the domestic pharmaceutical market. Recently, STADA-VN has held a “Customer Conference” in Binh Duong province on 18 June 2011.

06 May 2011

Conference and Exhibition on Drug On 06 May 2011

On 06 May 2011, STADA-VN has participated in the Conference and Exhibition on Drug held by Ho Chi Minh City Health Department together with more than 40 pharmaceutical manufacturers.

25 Apr 2011

Medical examination and treatment activities for the poor

On 24/04/2011, STADA-VN as a sponsor has coordinated with Hospital 115 held the medical examination and treatment activities for the poor in Tra Vinh Province. There are over 500 people received medicines from the activities.

11 Apr 2011

Month of Food Safety, Hygiene and Quality

With the mission “Towards the community health”, STADA-VN has attended to the parade of Food Safety, Hygiene and Quality held on April 09, 2011 in Binh Duong Province.

07 Apr 2011

Online Consulting: “Nutrition and Weight Loss”

To help customers learn more about methods for losing weight safely and effectively, STADA-Vietnam Joint Venture Co., Ltd. and Thanh Nien Online held together a successful online consulting of “Nutrition and Weight Loss” on April 07,

14 Mar 2011

Seminar “Update on the progress for the treatment of hypertension and coronary artery disease”

On March 12, 2011, STADA-VN organized the seminar, “Update on the progress for the treatment of Hypertension and Coronary Artery Disease” lectured by Assoc. Prof. Pham Nguyen Vinh – Vice Chairman of Vietnam Cardiovascular Association, Director of Tam Duc Heart Hospital.

10 Mar 2011

Conference on Orlistat STADA in Ho Chi Minh City

Following the advertising campaign of April 2010 for the Orlistat STADA Diet Pill, on 08 January 2011, STADA – VN JOINT VENTURE CO., LTD cooperated with our exclusive distributor – Khuong Duy Pharmaceutical Co., Ltd to organize a meeting for our customers in Ho Chi Minh City.

28 Feb 2011

New Year Meeting for Provincial Agents

In cooperation with our exclusive distributor – Khuong Duy Pharmaceutical Co., Ltd, on 28 February 2011, STADA – VN JOINT VENTURE CO., LTD held a New Year Meeting for all KD’s Chief of Representative Office and provincial agents.

24 Jan 2011

Year-end party 2010

In the happy and rejoiced atmosphere of the first days of the year, on 22 January 2011, STADA – VN JOINT VENTURE CO., LTD organized the 2010 year-end party with the topic “STADA – Continuous Development”. The party was hosted at Factory No. II

23 Jan 2011

End of Year Party of Pharmaceutical Association

As a co-sponsor, on 22 January 2011, STADA – VN JOINT VENTURE CO., LTD was pleased to join the Year-end party of HCMC Pharmaceutical Association held at the Faculty of Pharmacy of HCMC.

24 Jun 2010

Cardiovascular Seminars

In the second quarter of 2010, STADA-VN held a series of Cardiovascular Seminars for hospital doctors working outside Ho Chi Minh City.

29 Apr 2010

Customer Conferences in provinces throughout Vietnam

STADA-VN has been acknowledged as one of the most prestigious enterprises in the domestic pharmaceutical market. Recently, STADA-VN has held several “Customer Conferences” in provinces throughout Vietnam.

20 Mar 2010

Training Workshop

QC Training workshop: A training workshop by Dr. Carmen González Espínola – Senior Manager Quality Assurance from STADA Arzneimittel AG was conducted at STADA-VN, VSIP factory from 15 to 19 March 2010.

13 Dec 2009

Funding to Overcome Consequences of Natural Calamity

Recently, the storm No. 11 landed in the central provinces of Vietnam caused severe devastation, materially as well as mentally, to the residents therein.